Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
05 June 2019 | Story Ruan Bruwer
Louzanne Coetzee
Athlete Louzanne Coetzee with the trophy of the Free State Sports Association for the Physically Disabled as Sports Star of the Year.
Although challenging, very exciting and a new journey, says Louzanne Coetzee about the athletics year for which she has been recognised.

The 26-year-old, who is doing her master’s in Social Cohesion and Reconciliation Studies at the University of the Free State, won the Free State Sports Association for the Physically Disabled (FSSAPD) Sports Star of the Year award for a fourth consecutive time. This was for the period June 2018 to April 2019.

In that time, she set a world record, an Africa record, and ran two marathons in which she came amazingly close to a second world record.

Only in her second marathon at the Berlin Marathon in September, the Paralympian fell 26 seconds short of the T11 (totally blind) world record time. She met the qualifying time for the 2020 Paralympic Games in Tokyo during the London Marathon in April.

“Marathons are definitely challenging and a new field for me, but I would say it has been a good 12 months. My aim is now set on next year’s Paralympic Games, where I would like to compete in the marathon and the 1 500 m.”

“I hope to run a good time in the 1 500 m at the World Para Athletics Championships in November.”

At the SASAPD National Championships for physically disabled and visually impaired athletes in April 2019, Coetzee won three gold medals and set a record in the 1 500 m. 

Others from the UFS also honoured

Coetzee has received several awards in her career, but says it is always special to be rewarded by her own federation (FSSAPD). 

Danie Breitenbach (T11) was also honoured as the Senior Male Sports Star. He bagged two gold medals and one silver and set a SA record in both the 800 m and 1 500 m at the nationals. Another Kovsie, Dineo Mokhosoa (F36 – coordination impairments), received a merit award for her gold medal in shot-put and silver in the discus at the national champs.

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept